Results for tag: "Respiratory Partnering"

The Respiratory Partnering market is a subset of the pharmaceutical industry focused on the development of drugs to treat respiratory diseases. These diseases include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory conditions. Companies in this market collaborate with each other to develop new treatments and therapies, as well as to share resources and expertise. Partnering agreements between companies in the Respiratory Partnering market can take many forms, such as joint ventures, licensing agreements, and research collaborations. These agreements are designed to help companies develop new treatments and therapies more quickly and cost-effectively. Some of the major players in the Respiratory Partnering market include AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Other companies in the market include Boehringer Ingelheim, Cipla, Daiichi Sankyo, and Teva Pharmaceuticals. Show Less Read more